Update on Emergency Contraception: Panel Discussion
On Demand Sessions:
*By clicking the webinar with credit link, you confirm that you have read the accreditation information on this page.
By the end of this webinar, participants will be able to:
- Discuss the latest research and regulatory decisions about EC efficacy and weight.
- Discuss the mechanism of action of EC, repeated use of EC, and the latest recommendations for providing hormonal contraception after EC.
- Address frequently-asked patient concerns and questions about EC.
Continuing Medical Education Credits: ARHP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education Credits: ARHP is approved by the California Board of Registered Nursing, Provider Number 16643, to provide nursing continuing education credits. Emergency Contraception Panel Discussion is approved for 1.0 contact hours.
This program is sponsored by the Association of Reproductive Health Professionals.
This project and webinar is funded through educational grants from Afaxys.
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Advisory Committee Disclosures
Donald F. Downing, RPH has nothing to disclose. Beth Kruse, MS, CNM, ARNP has nothing to disclose. James Trussell, PhD, has nothing to disclose. David Turok, MD, MPH is a speaker for Actavis and Medicines360.
ARHP Staff/Consultant Disclosures
Emily Kane-Lee has no affiliations to disclose.